DIMTRUZIC 240mg gastro-resistant capsules medication leaflet

L04AX07 dimethyl fumarate • Antineoplastic and immunomodulating agents | Immunosuppressants | Other immunosuppressants

Dimethyl fumarate is a medication used for the treatment of relapsing-remitting multiple sclerosis. It works by reducing inflammation and protecting nerve cells from oxidative stress.

The medication is taken orally, usually twice daily, as directed by a doctor. It is important to follow the recommended dose to minimize the risk of adverse effects.

Side effects may include flushing, nausea, diarrhea, abdominal pain, or a decrease in lymphocyte count. In rare cases, severe allergic reactions or progressive multifocal leukoencephalopathy may occur.

Dimethyl fumarate is not recommended for patients with hypersensitivity to this medication or active severe infections.

General data about DIMTRUZIC 240mg

Substance: dimethyl fumarate

Date of last drug list: 01-07-2024

Commercial code: W70348004

Concentration: 240mg

Pharmaceutical form: gastro-resistant capsules

Quantity: 168

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: LEK PHARMACEUTICALS D.D. - SLOVENIA

Holder: SANDOZ PHARMACEUTICALS S.R.L. - ROMANIA

Number: 14825/2022/04

Shelf life: 3 years

Pharmaceutical forms available for dimethyl fumarate

Concentrations available for dimethyl fumarate

120mg, 240mg, 30mg